US Stocks
/
Bolt Biotherapeutics, Inc. Share Price
Bolt Biotherapeutics, Inc. Share Price

Bolt Biotherapeutics, Inc. Share Price

NASDAQ: BOLT | Micro Cap
$3.61
+$3.61 (--%) Last updated on 08 Oct, 2026 | 01:19 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Bolt Biotherapeutics, Inc. Stock Performance

Open
$3.72
Prev. Close
N/A
Circuit Range
N/A
Day Range
$3.51 - $3.75
Year Range
$3.14 - $6.87
Volume
3,700
Average Traded
$3.55

Bolt Biotherapeutics, Inc. Share Price Chart

$3.51$3.75
L
Show Current Price
H

Bolt Biotherapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$6.75M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-14.92
Revenue (TTM)
$7.70B
Return On Equity (TTM)
-227.37%
Profit Margin
-433.51%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-8.12%

Bolt Biotherapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$2.17$2.50$0.03$0.01
Net Profit-$7.14-$6.63-$7.24-$7.72
Net Profit Margin-329.03%-265.20%-24133.33%-77200.00%
Income ChangeN/A7.14%-9.20%-6.63%

Bolt Biotherapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$5.73$7.88$7.69$7.70
Net Profit-$88.10-$69.20-$63.12-$33.38
Net Profit Margin-1537.52%-878.17%-820.81%-433.51%
Income ChangeN/A21.45%8.79%47.12%

About Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

Bolt Biotherapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.72
$3.61
-0.55%
Sep 2026
$3.69
$3.63
-6.68%
Aug 2026
$3.84
$3.89
-2.87%
Jul 2026
$3.83
$4.00
+4.03%
Jun 2026
$5.48
$3.85
-26.39%
May 2026
$4.82
$5.23
+9.41%
Apr 2026
$4.51
$4.78
+16.02%
Mar 2026
$4.54
$4.12
-7.62%
Feb 2026
$5.76
$4.46
-27.00%
Jan 2026
$6.02
$6.11
+12.94%
Dec 2025
$5.00
$5.41
+11.55%
Nov 2025
$5.51
$4.85
-17.24%

BOLT Share Price FAQs

What is Bolt Biotherapeutics, Inc. share price today?

chevron-up
Bolt Biotherapeutics, Inc. share price today is $3.61 as on October 8, 2026 at 1:19 am IST.

What is the 52 week high and 52 week low of Bolt Biotherapeutics, Inc. stock?

chevron-up
The 52 week high of Bolt Biotherapeutics, Inc. stock is $6.87, while the 52 week low is $3.14 as of 8 Oct '26.

What is BOLT's market capitalisation today?

chevron-up
BOLT market capitalisation is $6.75M as of October 10, 2026, at 4:40 am IST.

What is BOLT's net income for the last quarter?

chevron-up
BOLT's net income for the last quarter is -7.72B USD.

What is the 5 year returns of BOLT?

chevron-up
The 5 year returns of BOLT is -98.62% as on 8 Oct '26.

What is the high & low stock price of BOLT today?

chevron-up
BOLT stock price hit a high of $3.75 and low of $3.51 as of 8 Oct '26.

Can I buy BOLT shares in India?

chevron-up
Yes. You can buy BOLT in India by opening an international trading account.